Freestone Capital Holdings’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$214K Sell
3,341
-64
-2% -$4.21K 0.01% 565
2026
Q1
$242K Buy
3,405
+134
+4% +$10.6K 0.01% 483
2025
Q4
$268K Sell
3,271
-228
-7% -$17.8K 0.01% 450
2025
Q3
$263K Sell
3,499
-41
-1% -$3.06K 0.01% 454
2025
Q2
$262K Buy
3,540
+86
+2% +$5.99K 0.01% 388
2025
Q1
$279K Buy
3,454
+169
+5% +$14.5K 0.01% 362
2024
Q4
$257K Sell
3,285
-9
-0.3% -$765 0.01% 371
2024
Q3
$309K Buy
3,294
+93
+3% +$7.81K 0.01% 351
2024
Q2
$249K Buy
3,201
+84
+3% +$6.85K 0.01% 408
2024
Q1
$283K Sell
3,117
-6
-0.2% -$499 0.01% 376
2023
Q4
$241K Buy
3,123
+53
+2% +$3.71K 0.01% 358
2023
Q3
$209K Buy
+3,070
New +$223K 0.01% 337

Other funds holding GEHC

Freestone Capital Holdings's GEHC Position: Q2 2026 in Review

Freestone Capital Holdings reduced its GE HealthCare (GEHC) stake by 1.9% in Q2 2026, selling an estimated $4.21K and leaving 3,341 shares worth $214K. The position accounts for 0.01% of the portfolio, ranked #565.

Freestone Capital Holdings first reported a position in GEHC in Q3 2023 and has held it in 12 quarters since. The position peaked at $309K in Q3 2024. 1,226 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Freestone Capital Holdings held 3,341 shares of GE HealthCare worth $214K as of Q2 2026.
  • Freestone Capital Holdings sold 64 GE HealthCare shares in Q2 2026, an estimated $4.21K.
  • GE HealthCare made up 0.01% of Freestone Capital Holdings's portfolio in Q2 2026, its #565 holding.
  • Freestone Capital Holdings first reported a position in GE HealthCare in Q3 2023 and has held it in 12 quarters since.
  • Freestone Capital Holdings's GE HealthCare position peaked at $309K in Q3 2024.
  • 1,226 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Freestone Capital Holdings's 13F filing for Q2 2026, filed 31 Jul 2026.